Tower Research Capital LLC (Trc) Vivos Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.31 - $0.55 $2,675 - $4,747	-8,631 Reduced 25.99%	24,573 $12,000
Q1 2023 May 09, 2023	BUY	$0.32 - $1.88 $5,208 - $30,602	16,278 Added 96.17%	33,204 $11,000
Q4 2022 Feb 10, 2023	BUY	$0.35 - $20.75 $1,278 - $75,799	3,653 Added 27.52%	16,926 $7,000
Q3 2022 Nov 10, 2022	BUY	$0.83 - $21.25 $8,112 - $207,697	9,774 Added 279.34%	13,273 $9,000
Q2 2022 Aug 15, 2022	SELL	$1.12 - $2.18 $343 - $669	-307 Reduced 8.07%	3,499 $5,000
Q1 2022 May 12, 2022	SELL	$1.63 - $3.63 $2,668 - $5,942	-1,637 Reduced 30.08%	3,806 $10,000
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.11 $72,423 - $132,292	-32,188 Reduced 85.54%	5,443 $12,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $5.9 $101,980 - $222,022	37,631 New	37,631 $152,000
Q2 2021 Aug 16, 2021	SELL	$4.83 - $9.67 $1,767 - $3,539	-366 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.01 - $8.9 $2,199 - $3,257	366 New	366 $2,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.